Abstract

Elite rugby league and union have some of the highest reported rates of concussion (mild traumatic brain injury) in professional sport due in part to their full-contact high-velocity collision-based nature. Currently, concussions are the most commonly reported match injury during the tackle for both the ball carrier and the tackler (8–28 concussions per 1000 player match hours) and reports exist of reduced cognitive function and long-term health consequences that can end a playing career and produce continued ill health. Concussion is a complex phenotype, influenced by environmental factors and an individual’s genetic predisposition. This article reviews concussion incidence within elite rugby and addresses the biomechanics and pathophysiology of concussion and how genetic predisposition may influence incidence, severity and outcome. Associations have been reported between a variety of genetic variants and traumatic brain injury. However, little effort has been devoted to the study of genetic associations with concussion within elite rugby players. Due to a growing understanding of the molecular characteristics underpinning the pathophysiology of concussion, investigating genetic variation within elite rugby is a viable and worthy proposition. Therefore, we propose from this review that several genetic variants within or near candidate genes of interest, namely APOE, MAPT, IL6R, COMT, SLC6A4, 5-HTTLPR, DRD2, DRD4, ANKK1, BDNF and GRIN2A, warrant further study within elite rugby and other sports involving high-velocity collisions.

Highlights

  • Mc Fie et al [21] reported that Met carriers in a cohort of youth and professional South African RU players were ~3-fold more likely to have a history of concussion and, it has been postulated that elevated dopamine could increase impulsivity and risk taking meaning Met allele carriers could place themselves at increased risk of sustaining a concussion [170,171]

  • A SNP exists at residue 358 of the interleukin 6 receptor (IL6R) gene (Supplementary Figure S16), the CC genotype of which has been associated with an increased risk of concussion in college athletes [22]

  • Elite rugby players are exposed to a higher risk of concussion during a playing career than athletes in many other sports

Read more

Summary

Introduction

There is a reported increased risk of potential short- and long-term consequences associated with concussion such as increased injury risk, cognitive impairment, forms of dementia, chronic post-concussion syndrome, migraines, sleep dysfunction, anxiety, post-traumatic stress disorder and second-impact syndrome [5,6,7,8,9,10,11,12,13,14]. A classical study on the inheritance of concussion risk, to elucidate the relative contribution of environmental versus genetic factors affecting inter-individual variability in concussion incidence, severity and outcome, would be extremely valuable. Substantial heritability estimates for brain structure (~90%) and cognitive performance (~60%) have been reported [31,32,33,34] Given these and other observations of substantial genetic contributions to inter-individual variability in most human traits, it is likely that a substantial genetic component applies to concussion. The aims of this narrative review are to (1) describe the current data on incidence rates and severity of concussion in elite rugby; (2) provide an overview of the mechanisms and pathophysiology of concussion; (3) evaluate how genetic variation could affect predisposition for and recovery from concussion; and (4) inform the future direction research regarding genetic aspects of concussion in rugby

Incidence Rate and Severity of Concussion in Rugby
Pathophysiology of Concussion
Genetic
Candidate Genetic Variants
Apolipoprotein E
Microtubule-Associated Protein Tau Polymorphisms
Neurofilament Heavy Polymorphism
Membrane Metalloendopeptidase Polymorphism
Brain-Derived Neurotrophic Factor Polymorphism
Glutamate Ionotropic Receptor NMDA Type Subunit 2A Variant
Catechol-O-methyltransferase Polymorphism
Ankyrin Repeat and Kinase Domain Containing 1 Polymorphism
Dopamine Receptor-Related Polymorphisms
5.1.10. Serotonin Transporter Polymorphisms
5.1.11. Endothelial Nitric Oxide Synthase Polymorphism
5.1.12. Angiotensin I-Converting Enzyme Variants
5.1.13. Tumour Necrosis Factor Polymorphisms
5.1.14. Transforming Growth Factor Beta1 Polymorphism
5.1.15. Interleukin 1 Alpha and Interleukin 1 Beta Polymorphisms
5.1.16. Interleukin 6 Receptor Polymorphism
Conclusions and Future Directions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.